Co-Authors
This is a "connection" page, showing publications co-authored by Adam Moore and Nathan Grubaugh.
Connection Strength
0.972
-
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
Score: 0.230
-
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
Score: 0.223
-
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 Jul; 27(7):1309.
Score: 0.060
-
Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 07; 27(7):1178-1186.
Score: 0.059
-
Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y). 2021 May 14; 2(5):591-610.e10.
Score: 0.059
-
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
Score: 0.059
-
Tracking smell loss to identify healthcare workers with SARS-CoV-2 infection. PLoS One. 2021; 16(3):e0248025.
Score: 0.058
-
Detection of SARS-CoV-2 RNA by multiplex RT-qPCR. PLoS Biol. 2020 10; 18(10):e3000867.
Score: 0.057
-
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
Score: 0.056
-
Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 12; 588(7837):315-320.
Score: 0.056
-
Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020 08; 584(7821):463-469.
Score: 0.056